Nurix Therapeutics, Inc. Contracts & Agreements
44 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (10)
- Human Resources (10)
- Real Estate (10)
- Uncategorized (4)
- Third Amendment to Lease Agreement, dated September 13, 2024, by and between ARE-San Francisco No. 19 Owner, LLC and the Registrant (Filed With SEC on October 11, 2024)
- Fifth Amendment to Lease Agreement, dated September 13, 2024, by and between ARE-San Francisco No. 26 Owner, LLC and the Registrant (Filed With SEC on October 11, 2024)
- Fourth Amendment to Lease Agreement, dated April 30, 2021, by and between ARE-San Francisco No. 26 Owner, LLC and the Registrant (Filed With SEC on October 11, 2024)
- Third Amendment to Lease Agreement, dated March 2, 2021, by and between ARE-San Francisco No. 26 Owner, LLC and the Registrant (Filed With SEC on October 11, 2024)
- Amendment No. 1 to the Equity Distribution Agreement, dated July 11, 2024, by and between Nurix Therapeutics, Inc. and Piper Sandler & Co (Filed With SEC on July 11, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on April 12, 2024)
- Underwriting Agreement by and among Nurix Therapeutics, Inc. and J.P. Morgan Securities LLC, Piper Sandler & Co. and Stifel, Nicolaus & Company, Incorporated as Representatives of... (Filed With SEC on April 12, 2024)
- Second Amendment to Lease Agreement, dated March 25, 2024, by and between ARE-San Francisco No. 19 Owner, LLC and the Registrant (Filed With SEC on April 10, 2024)
- Sixth Amendment to Collaboration and License Agreement, dated March 6, 2024, by and between the Registrant and Genzyme Corporation (Filed With SEC on April 10, 2024)
- Fifth Amendment to Collaboration and License Agreement, dated November 3, 2023, by and between the Registrant and Genzyme Corporation (Filed With SEC on February 15, 2024)
- First Amendment to Lease Agreement, dated August 25, 2023, by and between 8800 Technology Forest PL, LLC and the Registrant (Filed With SEC on October 12, 2023)
- First Amendment to Lease Agreement, dated June 28, 2023, by and between ARE-San Francisco No. 19 Owner, LLC and the Registrant (Filed With SEC on October 12, 2023)
- Description of Registrants Securities (Filed With SEC on February 9, 2023)
- Fourth Amendment to Collaboration and License Agreement, dated August 11, 2022, by and between the Registrant and Genzyme Corporation (Filed With SEC on October 6, 2022)
- Third Amendment to Collaboration and License Agreement, dated July 7, 2022, by and between the Registrant and Genzyme Corporation (Filed With SEC on October 6, 2022)
- Second Amendment to Collaboration and License Agreement, dated December 16, 2021, by and between the Registrant and Genzyme Corporation (Filed With SEC on October 6, 2022)
- Second Amendment to Collaboration, Option and License Agreement, dated September 9, 2022, by and between the Registrant and Gilead Sciences, Inc (Filed With SEC on October 6, 2022)
- First Amendment to Collaboration, Option and License Agreement, dated August 13, 2019, by and between the Registrant and Gilead Sciences, Inc (Filed With SEC on October 6, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on July 8, 2022)
- Form of Pre-funded Warrant (Filed With SEC on July 8, 2022)
- Lease Agreement, dated as of March 1, 2022, between 8800 Technology Forest Pl, LLC and the Registrant (Filed With SEC on April 8, 2022)
- Executive Severance and Change in Control Plan, as amended and restated on January 19, 2022, and form of Participation Agreement thereunder (Filed With SEC on January 28, 2022)
- Employment Agreement, dated July 15, 2020, by and between the Registrant and Hans van Houte (Filed With SEC on January 28, 2022)
- Lease Agreement, dated as of June 21, 2021, between ARE-San Francisco No. 19 LLC and the Registrant (Filed With SEC on October 14, 2021)
- Employment Agreement, dated June 10, 2021, by and between the Registrant and Stefani Wolff (Filed With SEC on October 14, 2021)
- Form of Underwriting Agreement (Filed With SEC on March 2, 2021)
- First Amendment to Collaboration and License Agreement, dated January 6, 2021, by and between the Registrant and Genzyme Corporation (Filed With SEC on February 16, 2021)
- Employment Agreement, dated July 15, 2020, by and between the Registrant and Christine Ring (Filed With SEC on February 16, 2021)
- Description of Registrants Securities (Filed With SEC on February 16, 2021)
- Employment Agreement, dated July 15, 2020, by and between the Registrant and Arthur T. Sands (Filed With SEC on July 20, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 20, 2020)
- 2020 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on July 20, 2020)
- 2020 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on July 20, 2020)
- Employment Agreement, dated July 15, 2020, by and between the Registrant and Pierre Beaurang (Filed With SEC on July 20, 2020)
- Employment Agreement, dated July 15, 2020, by and between the Registrant and Gwenn Hansen (Filed With SEC on July 20, 2020)
- Form of Severance and Change in Control Agreement (Filed With SEC on July 20, 2020)
- Form of Common Stock Certificate (Filed With SEC on July 2, 2020)
- Letter Agreement, dated June 15, 2020, by and between the Registrant and Arthur T. Sands (Filed With SEC on July 2, 2020)
- Collaboration and License Agreement, dated December 19, 2019, by and between the Registrant and Genzyme Corporation (Filed With SEC on July 2, 2020)
- Collaboration, Option and License Agreement, dated June 10, 2019, by and between the Registrant and Gilead Sciences, Inc., as amended (Filed With SEC on July 2, 2020)
- Lease Agreement dated as of March 24, 2014, as amended, ARE-San Francisco No. 26, LLC (Filed With SEC on July 2, 2020)
- 2012 Equity Incentive Plan, as amended, and forms of award agreements (Filed With SEC on July 2, 2020)
- Form of Indemnity Agreement (Filed With SEC on July 2, 2020)
- Amended and Restated Investors Rights Agreement, dated March 9, 2020, by and among the Registrant and certain of its stockholders (Filed With SEC on July 2, 2020)
